Clinical activity of sunitinib in patients with advanced desmoplastic round cell tumor: a case series
被引:39
作者:
Italiano, Antoine
论文数: 0引用数: 0
h-index: 0
机构:
Inst Bergonie, Dept Med Oncol, F-33076 Bordeaux, FranceInst Bergonie, Dept Med Oncol, F-33076 Bordeaux, France
Italiano, Antoine
[1
]
Kind, Michele
论文数: 0引用数: 0
h-index: 0
机构:
Inst Bergonie, Dept Radiol, F-33076 Bordeaux, FranceInst Bergonie, Dept Med Oncol, F-33076 Bordeaux, France
Kind, Michele
[2
]
Cioffi, Angela
论文数: 0引用数: 0
h-index: 0
机构:
Inst Gustave Roussy, Dept Med, Villejuif, FranceInst Bergonie, Dept Med Oncol, F-33076 Bordeaux, France
Cioffi, Angela
[3
]
Maki, Robert G.
论文数: 0引用数: 0
h-index: 0
机构:
Mem Sloan Kettering Canc Ctr, Sarcoma Serv, New York, NY 10021 USA
Mt Sinai Sch Med, New York, NY USAInst Bergonie, Dept Med Oncol, F-33076 Bordeaux, France
Maki, Robert G.
[4
,5
]
Bui, Binh
论文数: 0引用数: 0
h-index: 0
机构:
Inst Bergonie, Dept Med Oncol, F-33076 Bordeaux, FranceInst Bergonie, Dept Med Oncol, F-33076 Bordeaux, France
Bui, Binh
[1
]
机构:
[1] Inst Bergonie, Dept Med Oncol, F-33076 Bordeaux, France
[2] Inst Bergonie, Dept Radiol, F-33076 Bordeaux, France
[3] Inst Gustave Roussy, Dept Med, Villejuif, France
[4] Mem Sloan Kettering Canc Ctr, Sarcoma Serv, New York, NY 10021 USA
Desmoplastic small round cell tumor (DSRCT) is a rare and aggressive malignancy with poor outcome occurring in adolescents and young adults. Therapeutic options for patients with advanced disease are limited. Preclinical studies have shown that VEGFR-2 and VEGFA are overexpressed in DSRCT and that DSRCT xenografts were highly responsive to anti-VEGF agents such as bevacizumab. We report here the clinical activity of sunitinib in eight patients with DSCRT. Our data suggest that sunitinib may be associated with clinical benefit even in heavily pretreated patients.